World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
102
Citations
50359
World Ranking
658
National Ranking
384

Medicine

D-Index
102
Citations
50393
World Ranking
7538
National Ranking
3933

Jeffrey I. Cohen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jeffrey I. Cohen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 417 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jeffrey I. Cohen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey I. Cohen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 102 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2014 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Jeffrey I. Cohen is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily concerns medical sciences, with a strong focus on infectious diseases, immunology, oncology, epidemiology, and genetics. This broad spectrum reflects interdisciplinary efforts spanning 238 publications in medicine.

The scientist's subfields of study include:

  • Infectious Diseases
  • Immunology
  • Oncology
  • Epidemiology
  • Genetics

Main topics covered by their research involve:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Viral-associated cancers and disorders
  • Herpesvirus Infections and Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Lymphoma Diagnosis and Treatment
  • Cytomegalovirus and herpesvirus research

Recent publications by Jeffrey I. Cohen include the following papers:

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19, 2020, Science
  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • SARS-CoV-2 infection and persistence in the human body and brain at autopsy, 2022, Nature
  • Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019, 2020, The Journal of Infectious Diseases
  • An immune-based biomarker signature is associated with mortality in COVID-19 patients, 2020, JCI Insight

Jeffrey I. Cohen has frequently published in the following venues:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • Journal of Allergy and Clinical Immunology
  • Transplantation and Cellular Therapy

The scientist has collaborated multiple times with coauthors including:

  • Peter D. Burbelo
  • Luigi D. Notarangelo
  • Ottavia M. Delmonte
  • Kerry Dobbs
  • Steven M. Holland

In recognition of their contributions, Jeffrey I. Cohen was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2014.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

    S. Hacein-Bey-Abina;C. Von Kalle;C. Von Kalle;M. Schmidt;M. P. McCormack

  • Autoantibodies against type I IFNs in patients with life-threatening COVID-19.

    Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis

  • Epstein-Barr Virus Infection

    Jeffrey I. Cohen

  • Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.

    Zhengbin Yao;William C. Fanslow;Michael F. Seldin;Anne Marie Rousseau

  • SARS-CoV-2 infection and persistence in the human body and brain at autopsy

    Unknown

  • Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

    L Young;C Alfieri;K Hennessy;H Evans

  • Varicella zoster virus infection.

    Anne A. Gershon;Judith Breuer;Jeffrey I. Cohen;Randall J. Cohrs

  • Clinical practice: Herpes zoster.

    Jeffrey I Cohen

  • VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease.

    Jeonghan Kim;Rajeev Gupta;Luz P. Blanco;Shutong Yang

  • Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

    Carrie L Lucas;Hye Sun Kuehn;Fang Zhao;Julie E Niemela

  • Second messenger role for Mg2+ revealed by human T-cell immunodeficiency

    Feng-Yen Li;Benjamin Chaigne-Delalande;Chrysi Kanellopoulou;Jeremiah C. Davis

  • Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis

    John Bertin;Robert C. Armstrong;Sabine Ottilie;David A. Martin

  • Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management

    Stephen E. Straus;Jeffrey I. Cohen;Giovanna Tosato;Jeffery Meier

  • Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

    Jeffrey I. Cohen;Anthony S. Fauci;Harold Varmus;Gary J. Nabel;Gary J. Nabel

  • Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.

    Ashish Jain;Chi Adrian Ma;Shiyung Liu;Margaret Brown

  • Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

    F. Wang;So-Fai Tsang;M. G. Kurilla;J. I. Cohen

  • Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses.

    J I Cohen;J R Ticehurst;R H Purcell;A Buckler-White

  • Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

    Jeffrey I. Cohen;Elaine S. Jaffe;Janet K. Dale;Stefania Pittaluga

  • Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D

    Benjamin Chaigne-Delalande;Feng-Yen Li;Feng-Yen Li;Geraldine M. O’Connor;Marshall J. Lukacs

  • Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

    Masaru Kanekiyo;Wei Bu;M. Gordon Joyce;Geng Meng

  • Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.

    Peter D Burbelo;Francis X Riedo;Chihiro Morishima;Stephen Rawlings

  • Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008

    J.I. Cohen;H. Kimura;S. Nakamura;Y.-H. Ko

  • Reactivation of Latent Epstein–Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas

    Wen Hai Feng;Jeffrey I. Cohen;Steven Fischer;Li Li

  • An immune-based biomarker signature is associated with mortality in COVID-19 patients.

    Michael S. Abers;Ottavia M. Delmonte;Emily E. Ricotta;Jonathan Fintzi

  • Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.

    Till Strowig;Cagan Gurer;Alexander Ploss;Yi-Fang Liu

  • A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory

    Andrea M. Siegel;Jennifer Heimall;Alexandra F. Freeman;Amy P. Hsu

Frequent Co-Authors

Peter D. Burbelo
Peter D. Burbelo National Institutes of Health
Sharon E. Straus
Sharon E. Straus University of Toronto
Stefania Pittaluga
Stefania Pittaluga National Institutes of Health
Gulbu Uzel
Gulbu Uzel National Institute of Allergy and Infectious Diseases
Sharon Walmsley
Sharon Walmsley University Health Network
Steven M. Holland
Steven M. Holland National Institute of Allergy and Infectious Diseases
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health
Elliott Kieff
Elliott Kieff Harvard University
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Michael J. Lenardo
Michael J. Lenardo National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing an online degree in immunology can open doors to various specialized healthcare careers, including roles as Nurse Practitioners (NPs). For those interested in advancing their clinical skills, finding the easiest np program may provide a smoother path to certification while balancing work and study commitments.

Mental health is a critical area closely linked to immunological research, particularly in understanding autoimmune and inflammatory disorders. Online options like the best pmhnp programs online offer robust clinical placements for Psychiatric Mental Health Nurse Practitioners, blending theoretical knowledge with practical experience.

Cost is a major factor when choosing a program. Many students look for the cheapest psych np programs to minimize financial burden without compromising the quality of education. This financial prudence can be critical for those balancing family and work responsibilities.

Career prospects in this field are promising, with Doctor of Nursing Practice (DNP) roles commanding competitive salaries. Exploring data on how much do dnps make can help candidates make informed decisions about where to study and work post-graduation.

Best Scientists Citing Jeffrey I. Cohen

Trending Scientists

Recently Published Articles